Jim Simons Plus Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.27 - $0.48 $50,203 - $89,251	185,940 Added 237.26%	264,310 $77,000
Q4 2022 Feb 13, 2023	BUY	$0.3 - $8.4 $2,241 - $62,748	7,470 Added 10.54%	78,370 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $7.5 $14,492 - $226,447	-30,193 Reduced 29.87%	70,900 $32,000
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.02 $15,518 - $34,409	33,735 Added 50.08%	101,093 $55,000
Q1 2022 May 13, 2022	SELL	$0.87 - $1.32 $121,053 - $183,667	-139,142 Reduced 67.38%	67,358 $67,000
Q4 2021 Feb 11, 2022	BUY	$1.03 - $1.94 $212,695 - $400,610	206,500 New	206,500 $217,000
Q3 2021 Nov 12, 2021	SELL	$1.83 - $2.46 $32,220 - $43,313	-17,607 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.0 - $2.89 $35,214 - $50,884	17,607 New	17,607 $45,000
Q1 2021 May 13, 2021	SELL	$2.1 - $3.75 $222,810 - $397,875	-106,100 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.0 - $2.76 $142,102 - $196,100	71,051 Added 202.72%	106,100 $214,000
Q3 2020 Nov 13, 2020	SELL	$2.11 - $3.17 $103,179 - $155,013	-48,900 Reduced 58.25%	35,049 $90,000
Q2 2020 Aug 13, 2020	BUY	$1.43 - $2.33 $4,147 - $6,757	2,900 Added 3.58%	83,949 $178,000
Q1 2020 May 14, 2020	SELL	$1.05 - $2.85 $4,814 - $13,067	-4,585 Reduced 5.35%	81,049 $152,000
Q4 2019 Feb 13, 2020	BUY	$1.99 - $3.23 $101,296 - $164,416	50,903 Added 146.56%	85,634 $206,000
Q3 2019 Nov 13, 2019	BUY	$3.3 - $19.25 $114,612 - $668,571	34,731 New	34,731 $119,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $46.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.